Lombard Odier Asset Management Switzerland SA Makes New Investment in The Clorox Company $CLX

Lombard Odier Asset Management Switzerland SA acquired a new position in The Clorox Company (NYSE:CLX) in the 4th quarter, HoldingsChannel reports. The firm acquired 101,000 shares of the company’s stock, valued at approximately $10,184,000.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Wilkins Investment Counsel Inc. raised its holdings in shares of Clorox by 250.6% in the fourth quarter. Wilkins Investment Counsel Inc. now owns 55,064 shares of the company’s stock valued at $5,552,000 after purchasing an additional 39,360 shares during the last quarter. JPMorgan Chase & Co. raised its holdings in shares of Clorox by 27.0% in the third quarter. JPMorgan Chase & Co. now owns 928,654 shares of the company’s stock valued at $114,506,000 after purchasing an additional 197,330 shares during the last quarter. Morningstar Investment Management LLC raised its holdings in shares of Clorox by 131.8% in the fourth quarter. Morningstar Investment Management LLC now owns 62,454 shares of the company’s stock valued at $6,297,000 after purchasing an additional 35,506 shares during the last quarter. Swiss Life Asset Management Ltd raised its holdings in shares of Clorox by 221.4% in the third quarter. Swiss Life Asset Management Ltd now owns 86,426 shares of the company’s stock valued at $10,656,000 after purchasing an additional 59,533 shares during the last quarter. Finally, Birch Hill Investment Advisors LLC purchased a new stake in shares of Clorox in the fourth quarter valued at about $22,103,000. 78.53% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several analysts have recently commented on the stock. Morgan Stanley lowered their target price on shares of Clorox from $110.00 to $97.00 and set an “equal weight” rating for the company in a report on Friday, May 1st. The Goldman Sachs Group reaffirmed a “sell” rating and set a $83.00 price target on shares of Clorox in a research report on Friday, May 1st. UBS Group decreased their price target on Clorox from $110.00 to $96.00 and set a “neutral” rating for the company in a research report on Friday, May 1st. Zacks Research downgraded Clorox from a “hold” rating to a “strong sell” rating in a research report on Tuesday, May 12th. Finally, Citigroup decreased their price objective on shares of Clorox from $110.00 to $97.00 and set a “neutral” rating for the company in a report on Friday, May 1st. One research analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and five have issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Reduce” and an average price target of $103.40.

Clorox Stock Performance

NYSE:CLX opened at $97.52 on Wednesday. The company has a debt-to-equity ratio of 27.03, a current ratio of 0.84 and a quick ratio of 0.65. The business has a fifty day simple moving average of $96.26 and a two-hundred day simple moving average of $105.05. The Clorox Company has a 1 year low of $84.70 and a 1 year high of $132.03. The company has a market capitalization of $11.79 billion, a P/E ratio of 15.83, a P/E/G ratio of 0.50 and a beta of 0.56.

Clorox (NYSE:CLX) last released its earnings results on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.55 by $0.09. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The business had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.67 billion. During the same period last year, the business posted $1.45 earnings per share. The business’s revenue for the quarter was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. On average, analysts expect that The Clorox Company will post 5.61 earnings per share for the current year.

Insider Transactions at Clorox

In other Clorox news, Director Pierre R. Breber bought 5,000 shares of Clorox stock in a transaction dated Tuesday, May 5th. The stock was purchased at an average price of $85.82 per share, for a total transaction of $429,100.00. Following the completion of the purchase, the director directly owned 18,000 shares of the company’s stock, valued at approximately $1,544,760. This trade represents a 38.46% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. 0.63% of the stock is owned by corporate insiders.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.